Maria Gonzalez Berlari
Family Medicine · Sun City, AZNPI 1861665796
Payments from drug & device makers
What this record shows
Novo Nordisk accounts for 61.6% of it on its own, with 26 other manufacturers making up the rest. Among family medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 376 payments — averaging $27.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$6K
- Boehringer Ingelheim$550
- AstraZeneca$470
- AbbVie$375
- GSK$330
- Amgen$309
- plus $2K from 21 others
What the payments were for
- Consulting fees$4,83048%
- Food & beverage$5,32152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 131 | $6,248 |
| Boehringer Ingelheim | 52 | $550 |
| AstraZeneca | 15 | $470 |
| AbbVie(2 entities) | 17 | $375 |
| GSK | 28 | $330 |
| Amgen | 18 | $309 |
| Abiomed | 6 | $297 |
| Johnson & Johnson | 16 | $280 |
| Lilly USA, LLC | 25 | $229 |
| Sanofi-aventis U.S. LLC | 13 | $190 |
| Amarin Pharma, Inc. | 9 | $155 |
| Novartis | 7 | $115 |
| Philips North America LLC | 9 | $114 |
| Pfizer | 7 | $112 |
| Abbott | 6 | $94 |
| Biohaven Pharmaceuticals, Inc. | 4 | $83 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
| Merck | 2 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $21 |
| Exact Sciences | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Bayer | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,151 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 179 | $321,649 |
| JardianceEmpagliflozin | 55 | $72,737 |
| FarxigaDapagliflozin Propanediol | 44 | $65,925 |
| TrulicityDulaglutide | 25 | $62,686 |
| RybelsusSemaglutide | 30 | $53,892 |
| EliquisApixaban | 22 | $34,159 |
| Repatha SyringeEvolocumab | 16 | $21,696 |
| Repatha SureclickEvolocumab | 16 | $19,222 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $19,119 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $17,108 |
| MyrbetriqMirabegron | 12 | $15,534 |
| VascepaIcosapent Ethyl | 12 | $12,837 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $7,140 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $6,523 |
| Atorvastatin Calcium | 474 | $4,589 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $6,248 | $375,541209 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $470 | $85,04457 claims |
| Boehringer IngelheimJardiance | $550 | $72,73755 claims |
| Lilly USA, LLCTrulicity | $229 | $62,68625 claims |
| PfizerEliquis | $112 | $34,15922 claims |
| GSKTrelegy Ellipta | $330 | $17,10813 claims |
| Sanofi-aventis U.S. LLCLantus | $190 | $1,13012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Sun City
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Lorena Jauregui-CovarrubiasYuma$491K
- Sam FereidouniScottsdale$486K
- Jessica BlancoChandler$447K
- Heather ElwoodPhoenix$236K
- Ryan CaseyYuma$231K
- Suzanne BentzMesa$174K
- Brent AllanParadise Valley$108K
- Ahmed AghaPhoenix$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.